For 2015 the consensus of the earnings per share of Merck KGaA & Co is at profit of 3,71 dollars. Based on this the price/earnings-ratio equals 14,85.
The consensus of the dividends per share is at 1,84 dollars. Consequently the dividend return is around 3,34 percent. On average the stocks in this sector yield a dividend return of around 0,65 percent.
The stock Merck KGaA & Co is covered by 6 analysts. The average target price for Merck KGaA & Co is at 75,29 dollars. This is 37 percent more than the current stock price of 55,08 dollars.
The stocks Evotec , Mithra and Kiadis in the sector The pharmaceutical sector have the most buy recommendations. The 3 most recent recommendations for the pharmaceutical sector were provided by BMO Capital Markets (hold, 62,00 dollars), Jefferies & Co. (hold, 51,00 dollars) and Credit Suisse (hold, 56,00 dollars).
Merck KGaA & Co's book value/price equals 0,33. The pharmaceutical sector now trades at a Shiller PE of 24.91. The stock now trades at 55,08 dollars. This equals 14 times the 2014's earnings per share.